Aura Biosciences
AURA
Aura Biosciences (AURA) news
Recent news
Aura Biosciences - May sell up to $200 mln common stock under sales agreement with Jefferies - SEC filing
Aura Biosciences, Inc. (Nasdaq: AURA) has announced plans to sell up to $200 million in common stock under a sales agreement with Jefferies, as disclosed in a recent SEC filing. The company filed a Form 8-K on August 11, 2026, outlining the terms of the agreement and related corporate updates. This…
AInvest Wire · Aug 11, 2026Aura Biosciences - May offer securities up to $500 mln aggregate - SEC filing
AInvest Wire · Aug 11, 2026AURA Biosciences, Inc.: H.C. Wainwright cuts target price to $18 from $24
AInvest Wire · Aug 11, 2026Aura Biosciences reduces workforce by about 20% to focus on ocular oncology
AInvest Wire · Aug 11, 2026Aura Biosciences: Organizational restructuring and capital allocation extend cash runway into 1H 2029
AInvest Wire · Aug 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.